Effect of Sensory Integration Therapy on Gait Variability and Quality Of Life in Patients With Multiple Sclerosis
What it found
We found no results in the registry or in papers.
What was tested
Treatment tested
- Conventional physical therapy program
- Sensory integration therapy
What it measured
Main measures
Step Length Variability
20 weeks
Walking and mobilityStep cycle Variability
20 weeks
Walking and mobilityWalking Speed Variability
20 weeks
Walking and mobilitySingle Support Time Variability (Time on Each Foot)
20 weeks
Walking and mobilityCoefficient of Variability of Gait (on each foot)
20 weeks
Walking and mobilityAmbulation Index
20 weeks
Walking and mobilityStep Length Variability (Smartphone-Based Assessment)
20 weeks
Disability progressionWalking and mobilitySafetyGait Velocity Variability (Smartphone-Based Assessment)
20 weeks
Walking and mobilityStep Time Variability (Smartphone-Based Assessment)
20 weeks
Walking and mobilityStep length symmetry (%) (Smartphone-Based Assessment)
20 weeks
Walking and mobilityStep time symmetry (%) (Smartphone-Based Assessment)
20 weeks
Walking and mobilityTotal Time (sec) (Smartphone-Based Assessment)
20 weeks
Walking and mobilityTimed 25 foot walk test
20 weeks
Disability progressionWalking and mobilitySafety
Other measures (1)
Short-form 36 quality of life's (SF-36)
20 weeks
Quality of life (reported by participants)
Who could take part
Relapsing MS · 18 to 45
Inclusion Criteria: * Male and female patients diagnosed with MS of relapsing-remitting at least 1 year before this study. * The Patient's age will range from 18-45. * A stable MS disease without any episodes of relapse within three months before the study. * The Expanded Disability Status Scale (EDSS) scale from medical documentation (2-4.5) involve that patients have (visual, cerebellum, pyramidal brainstem and sensory) problems. * Ability to walk six minutes' walk test (6 min walk test) Exclusion Criteria: * Orthopedic disorders such as contracture deformities that could negatively affect gait. * Other disorders affect gait and quality of life as (diabetes mellitus). * Other diseases that affect Visual and vestibular problems system (such as vestibular neuritis). * Marked spasticity grade (2,3,4) for bilateral lower extremities according to modified ashworth scale. * Pregnancy.
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
This study aims to evaluate the impact of sensory integration therapy on individuals with multiple sclerosis (MS) by examining its effects on gait variability and overall quality of life.
Loading reviews and guidelines…
History
Started
Feb 2026
Main results due
Jul 2026
Finished
Jul 2026
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error